| Title: | Family History and ASCVD Risk Among Different Age Groups Cohort Study in China and the United Kingdom |
| Journal: | JACC Asia |
| Published: | 30 Dec 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41712897/ |
| DOI: | https://doi.org/10.1016/j.jacasi.2025.10.031 |
Publication 18772
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Evidence on the association between family history and atherosclerotic cardiovascular disease (ASCVD) across age groups remains limited.</p>
OBJECTIVES: This study aimed to evaluate the relations of family history of ASCVD (FHA) with incident ASCVD and its predictive value across age groups in China-PAR (Prediction for Atherosclerotic Cardiovascular Disease Risk in China) and UK Biobank.</p>
METHODS: A total of 117,640 Chinese and 457,781 UK adults were included from 2 population-based cohorts, with family history assured by face-to-face interviews with standardized questionnaires.</p>
RESULTS: During median follow-ups of 6.0 (Q1-Q3: 5.7-11.4) years (China-PAR) and 11.8 (Q1-Q3: 11.0-12.5) years (UK Biobank), 4,681 and 26,913 ASCVD cases occurred. Generally, FHA was consistently associated with higher ASCVD risk, but the association weakened with age (Pinteraction < 0.001). The strongest effect was in adults <45 years, with HRs of 1.48 (95% CI: 1.11-1.96) in China-PAR and 1.47 (95% CI: 1.23-1.76) in UK Biobank, which was transformed to 6.75 and 5.33 years ASCVD-free years lost at the index of 20 years, and this gap decreased to 3.40 and 1.42 years at the index of 80 years, respectively. Notably, sibling history conferred greater risk than parental history (Pheterogeneity < 0.001).</p>
CONCLUSIONS: In both populations, FHA is a key indicator for identifying high ASCVD risk, especially in younger individuals, with a stronger impact driven by sibling history. These findings highlight the importance of tailoring recommendations for identifying high-risk individuals based on family history, with consideration of different age groups.</p>
20 Authors
- Chenxi Yuan
- Chong Shen
- Jianxin Li
- Keyong Huang
- Xueli Yang
- Jichun Chen
- Xiaoqing Liu
- Jie Cao
- Shufeng Chen
- Tao Zhou
- Ling Yu
- Yingxin Zhao
- Xianping Wu
- Liancheng Zhao
- Ying Li
- Dongsheng Hu
- Jianfeng Huang
- Xiangfeng Lu
- Fangchao Liu
- Dongfeng Gu
Enabling scientific discoveries that improve human health